GT Biopharma, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $14.1M
Liabilities Breakdown FY2023
Total Liabilities: $6.6M
Asset Breakdown
Total Assets: $14.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.1M | 7.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $13.0M | 92.4% |
Liabilities Breakdown
Total Liabilities: $6.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.3M | 65.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.3M | 34.8% |